2025
SJR Q2
JCR Q3 · 2,3
11 matched articles
SCIE
Journal detail
Pharmacopsychiatry
- Publisher
- Georg Thieme Verlag
- Country
- Germany · Western Europe
- Type
- journal
- ISSN
-
0176367914390795
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,868
- Quartile Q2
- H-Index 88
- Cites/doc 2,36
- Docs (3y) 108
- Cites (3y) 286
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,3
- 5Y JIF 3,3
- JCI 0,61
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Medicine (miscellaneous) Q2
- Pharmacology (medical) Q2
- Psychiatry and Mental Health Q2
Areas
- Medicine
WoS categories
- Pharmacology & Pharmacy | Psychiatry
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,868 | 2,3 | 3,3 | 0,61 | Q3 | 88 |
| 2024 | Q1 | Q3 | 0,943 | 2,2 | 3,2 | 0,72 | Q2 | 86 |
| 2023 | Q2 | Q1 | 0,834 | 3,6 | 4 | 0,75 | Q2 | 86 |
| 2022 | Q2 | Q2 | 0,583 | 4,3 | 4,4 | 0,62 | Q3 | 86 |
| 2021 | Q1 | Q3 | 0,942 | 2,5 | 3,9 | 0,57 | Q3 | 86 |
| 2020 | Q1 | Q1 | 1,174 | 5,8 | 3,6 | 0,71 | Q2 | 86 |
| 2019 | Q1 | Q1 | 1,003 | 4,3 | 2,7 | 0,83 | Q2 | 86 |
| 2018 | — | Q2 | — | 2,7 | 2 | 0,71 | Q2 | — |
| 2017 | Q2 | Q3 | 0,845 | 2,1 | 1,8 | 0,63 | Q3 | 86 |
| 2016 | Q2 | Q3 | 0,632 | 1,8 | 1,8 | — | — | 86 |
| 2015 | Q2 | Q3 | 0,654 | 1,5 | 1,9 | — | — | 86 |
| 2014 | Q1 | Q3 | 0,906 | 1,9 | 2,2 | — | — | 86 |
| 2013 | Q2 | Q2 | 0,75 | 2,2 | 2 | — | — | 86 |
| 2012 | Q1 | Q2 | 1,024 | 2,1 | 2,1 | — | — | 86 |
| 2011 | Q1 | Q3 | 0,834 | 2,1 | 1,7 | — | — | 86 |
| 2010 | Q1 | Q2 | 0,991 | 2,2 | 2,1 | — | — | 86 |
| 2009 | — | Q2 | — | 2,3 | 2,3 | — | — | — |
| 2008 | — | Q2 | — | 2,4 | 2,5 | — | — | — |
| 2007 | — | Q2 | — | 3,2 | 2,9 | — | — | — |
| 2006 | — | Q2 | — | 2,8 | — | — | — | — |
| 2005 | — | Q2 | — | 2,6 | — | — | — | — |
| 2004 | — | Q2 | — | 2,1 | — | — | — | — |
| 2003 | — | Q1 | — | 2,8 | — | — | — | — |
| 2002 | — | Q2 | — | 1,8 | — | — | — | — |
| 2001 | — | Q2 | — | 2 | — | — | — | — |
| 2000 | — | Q1 | — | 2,7 | — | — | — | — |
| 1999 | — | Q1 | — | 2,8 | — | — | — | — |
| 1998 | — | Q1 | — | 2,3 | — | — | — | — |
| 1997 | — | Q1 | — | 2,1 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 226/356 |
| 2025 | PSYCHIATRY | SCIE | Q3 | Q3 | 159/293 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 209/352 |
| 2024 | PSYCHIATRY | SCIE | Q3 | Q2 | 152/288 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 94/354 |
| 2023 | PSYCHIATRY | SCIE | Q1 | Q2 | 66/279 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q3 | 87/278 |
| 2022 | PSYCHIATRY | SCIE | Q2 | Q3 | 61/155 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 202/279 |
| 2021 | PSYCHIATRY | SCIE | Q4 | Q3 | 119/155 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q2 | 44/276 |
| 2020 | PSYCHIATRY | SCIE | Q1 | Q3 | 26/156 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q2 | 46/271 |
| 2019 | PSYCHIATRY | SCIE | Q1 | Q2 | 32/155 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 122/267 |
| 2018 | PSYCHIATRY | SCIE | Q2 | Q2 | 64/146 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 168/261 |
| 2017 | PSYCHIATRY | SCIE | Q3 | Q3 | 86/142 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 183/257 |
| 2016 | PSYCHIATRY | SCIE | Q3 | — | 92/142 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 194/255 |
| 2015 | PSYCHIATRY | SCIE | Q3 | — | 99/142 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 159/255 |
| 2014 | PSYCHIATRY | SCIE | Q3 | — | 84/140 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 134/256 |
| 2013 | PSYCHIATRY | SCIE | Q2 | — | 67/136 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 139/261 |
| 2012 | PSYCHIATRY | SCIE | Q2 | — | 67/135 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 138/261 |
| 2011 | PSYCHIATRY | SCIE | Q3 | — | 73/130 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 132/252 |
| 2010 | PSYCHIATRY | SCIE | Q2 | — | 61/128 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 120/237 |
| 2009 | PSYCHIATRY | SCIE | Q2 | — | 57/117 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 101/219 |
| 2008 | PSYCHIATRY | SCIE | Q2 | — | 50/101 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 53/205 |
| 2007 | PSYCHIATRY | SCIE | Q2 | — | 29/94 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 57/199 |
| 2006 | PSYCHIATRY | SCIE | Q2 | — | 32/94 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 57/193 |
| 2005 | PSYCHIATRY | SCIE | Q2 | — | 36/94 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 73/187 |
| 2004 | PSYCHIATRY | SCIE | Q2 | — | 41/90 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 46/185 |
| 2003 | PSYCHIATRY | SCIE | Q2 | — | 27/87 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 73/188 |
| 2002 | PSYCHIATRY | SCIE | Q2 | — | 42/88 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 55/186 |
| 2001 | PSYCHIATRY | SCIE | Q2 | — | 31/81 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 35/181 |
| 2000 | PSYCHIATRY | SCIE | Q1 | — | 18/82 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 26/175 |
| 1999 | PSYCHIATRY | SCIE | Q1 | — | 15/80 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 29/178 |
| 1998 | PSYCHIATRY | SCIE | Q1 | — | 18/77 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 33/157 |
| 1997 | PSYCHIATRY | SCIE | Q2 | — | 18/67 |